OTC Markets OTCPK - Delayed Quote USD

Tecan Group AG (TCHBF)

Compare
277.00 -33.00 (-10.65%)
As of October 21 at 10:56 AM EDT. Market Open.
Loading Chart for TCHBF
DELL
  • Previous Close 310.00
  • Open 277.00
  • Bid 265.45 x 3000
  • Ask 295.94 x 1200
  • Day's Range 277.00 - 277.00
  • 52 Week Range 277.00 - 400.00
  • Volume 5
  • Avg. Volume 5
  • Market Cap (intraday) 3.552B
  • Beta (5Y Monthly) 0.62
  • PE Ratio (TTM) 30.31
  • EPS (TTM) 9.14
  • Earnings Date Aug 13, 2024
  • Forward Dividend & Yield 3.29 (1.19%)
  • Ex-Dividend Date Apr 22, 2024
  • 1y Target Est --

Tecan Group AG provides laboratory instruments and solutions for pharmaceutical, biotechnology and in-vitro diagnostic companies, university research departments, and diagnostic and other laboratories. It operates through Life Sciences Business and Partnering Business segments. The company offers liquid handling and automation, microplate readers and washers, consumables, NGS reagents, immunoassays and antibodies, and software; and Tecan Labwerx, an automation solution. It provides PARAMIT, a contract design and manufacturing service. The company operates in Switzerland, Europe, Other European countries, North America, Asia, and internationally. Tecan Group AG was founded in 1980 and is headquartered in M?nnedorf, Switzerland.

www.tecan.com

3,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: TCHBF

View More

Performance Overview: TCHBF

Trailing total returns as of 10/22/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

TCHBF
26.75%
MSCI WORLD
17.61%

1-Year Return

TCHBF
9.96%
MSCI WORLD
33.54%

3-Year Return

TCHBF
51.16%
MSCI WORLD
18.24%

5-Year Return

TCHBF
24.19%
MSCI WORLD
68.71%

Compare To: TCHBF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: TCHBF

View More

Valuation Measures

Annual
As of 10/21/2024
  • Market Cap

    3.54B

  • Enterprise Value

    3.50B

  • Trailing P/E

    30.34

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.07

  • Price/Book (mrq)

    2.18

  • Enterprise Value/Revenue

    3.03

  • Enterprise Value/EBITDA

    17.46

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.13%

  • Return on Assets (ttm)

    2.94%

  • Return on Equity (ttm)

    7.37%

  • Revenue (ttm)

    1B

  • Net Income Avi to Common (ttm)

    101.34M

  • Diluted EPS (ttm)

    9.14

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    343.78M

  • Total Debt/Equity (mrq)

    22.44%

  • Levered Free Cash Flow (ttm)

    91.04M

Company Insights: TCHBF

People Also Watch